Literature DB >> 15970733

Affective outcome following carbon monoxide poisoning: a prospective longitudinal study.

Bruce W Jasper1, Ramona O Hopkins, Heather Van Duker, Lindell K Weaver.   

Abstract

OBJECTIVE: To longitudinally assess the prevalence of depression and anxiety following carbon monoxide (CO) poisoning and to assess the contributions of mode of poisoning (accidental versus suicide attempt), cognitive sequelae, and oxygen dose (hyperbaric oxygen versus normobaric oxygen) to depression and anxiety.
BACKGROUND: CO is the most common cause of poisoning in the United States and may result in neuropathologic changes and cognitive and neurologic sequelae, yet little is known regarding affective outcomes.
METHOD: We prospectively assessed affect in 127 CO-poisoned patients. Self-report inventories of depression and anxiety were administered at 6 weeks and at 6 and 12 months post CO poisoning. The primary outcome was prevalence of depression and anxiety at 6 weeks. To determine the effect of mode of poisoning, cognitive sequelae, and oxygen dose, odds ratio estimates were calculated at all three times using logistic regression.
RESULTS: Depression and anxiety were present in 45% of patients at 6 weeks, 44% at 6 months, and 43% at 12 months. Patients with suicide attempt and cognitive sequelae had higher prevalence of depression and anxiety at 6 weeks. At 12 months, there were no differences in depression or anxiety regardless of mode of poisoning, presence of cognitive sequelae, or oxygen dose.
CONCLUSIONS: CO poisoning results in significant depression and anxiety that persist to at least 12 months. Patients with cognitive sequelae and suicide attempt had a higher rate of depression and anxiety at 6 weeks but not at 12 months. Clinicians need to be aware of affective morbidity following CO poisoning and remain vigilant about CO prevention.

Entities:  

Mesh:

Year:  2005        PMID: 15970733     DOI: 10.1097/01.wnn.0000160820.07836.cf

Source DB:  PubMed          Journal:  Cogn Behav Neurol        ISSN: 1543-3633            Impact factor:   1.600


  7 in total

1.  Carbon monoxide: the case for environmental public health surveillance.

Authors:  Judith M Graber; Steven C Macdonald; Daniel E Kass; Andrew E Smith; Henry A Anderson
Journal:  Public Health Rep       Date:  2007 Mar-Apr       Impact factor: 2.792

2.  Acute Brain Lesions on Magnetic Resonance Imaging and Delayed Neurological Sequelae in Carbon Monoxide Poisoning.

Authors:  Sang-Beom Jeon; Chang Hwan Sohn; Dong-Woo Seo; Bum Jin Oh; Kyoung Soo Lim; Dong-Wha Kang; Won Young Kim
Journal:  JAMA Neurol       Date:  2018-04-01       Impact factor: 18.302

3.  Serum markers and development of delayed neuropsychological sequelae after acute carbon monoxide poisoning: anion gap, lactate, osmolarity, S100B protein, and interleukin-6.

Authors:  Hyukhoon Kim; Sangchun Choi; Eunjung Park; Eunhui Yoon; Younggi Min; Samsun Lampotang
Journal:  Clin Exp Emerg Med       Date:  2018-09-30

4.  Effect of ethanol in carbon monoxide poisoning and delayed neurologic sequelae: A prospective observational study.

Authors:  Sungwoo Choi; Sangsoo Han; Sangun Nah; Young Hwan Lee; Young Soon Cho; Hoon Lim; Myeong Sik Kim; Gi Woon Kim
Journal:  PLoS One       Date:  2021-01-11       Impact factor: 3.240

Review 5.  Inhalation injury: epidemiology, pathology, treatment strategies.

Authors:  David J Dries; Frederick W Endorf
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2013-04-19       Impact factor: 2.953

6.  Increased Long-Term Risk of Dementia in Patients With Carbon Monoxide Poisoning: A Population-Based Study.

Authors:  Chung-Shun Wong; Ying-Chin Lin; Li-Yee Hong; Tzu-Ting Chen; Hon-Ping Ma; Yung-Ho Hsu; Shin-Han Tsai; Yuh-Feng Lin; Mei-Yi Wu
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

7.  Patients With Carbon Monoxide Poisoning and Subsequent Dementia: A Population-Based Cohort Study.

Authors:  Ching-Yuan Lai; Yu-Wei Huang; Chun-Hung Tseng; Cheng-Li Lin; Fung-Chang Sung; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.